| |
| Magyar Diabetes Társaság |
|
| XVIII. Dunántúli Diabetes Hétvége |
 Rendezvény kezdete: 2013.04.12. | Rendezvény vége: 2013.04.14. |
| Szervező: AAC Kongresszusi Iroda |
| Címe: 8200 Veszprém, Templom u. 9. |
| Tel: 06 (88) 789 809 |
| Fax: 06 (88) 789 809 |
| E-mail: ddh2013@diabet.hu |
| Helyszín: 8237 Tihany, Rév u. 3., Club Tihany |
| A rendezvény Web oldala: http://diabet.hu/ddh2013 |
A rendezvényre történő regisztráció és szállásfoglalás az MDT honlapján keresztül történik.
ONLINE JELENTKEZÉS >> |
|
|
 |
| |
| Magyar Immunológiai Társaság |
|
| XXVI Congress of the International Society for Advancement of Cytometry |
| Rendezvény kezdete: 2011.05.21. | Rendezvény vége: 2011.05.25. |
| Helyszín: USA Maryland, Baltimore, |
| A rendezvény Web oldala: http://www.cytoconference.org |
CYTO 2011 will follow the same successful formula as CYTO 2010 with offerings to include:
• The CYTO Symposium - embedded in the middle of the congress reflecting the strengths in cytometry science and applications of the host region. The flexible format for the symposium gives the local organizing committee opportunities to give each CYTO a unique characteristic and provide a distinct platform for future partnered-events.
• State-of-the-Art in Cytometry Lectures addressing Technology, Science and Biomedicine – our way of getting the main meeting off to a great start and to ensure that we stay true to our origins.
• Frontiers Lectures and Plenary Talks – these highly regarded sessions will underpin an outstanding program.
• A new showcase session for Emergent Technologies And Engineering Innovations - showing the determination of ISAC to continue to acknowledge and support creativity in those areas.
• The Hooke Lecture - will continue to address the importance and responsibilities of our discipline framed within a wider context. We expect this to be both informative and inspirational.
• Parallel & poster sessions - for membership participation with an expanded process of peer review creating a high-value program, including a call for peer-reviewed Proceedings Papers to be presented at the meeting and published in Cytometry Part A.
• Workshops and tutorials – with topics that respond to the current needs of the membership with a strong input from affiliated organizations. |
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
| Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
| A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
|
